In one of its first actions, the Biden administration rejoined the United States in the World Health Organization, reversing a policy of its predecessor. . . . → Read More: U.S. Rejoins WHO, Participates in Int’l Vaccine Project
|
|||||
|
       
  |
A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections. . . . → Read More: Antibodies Prevent Covid-19 Symptoms in Long-Term Care 
A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon. . . . → Read More: Multi-Variant Covid-19 Vaccine in the Works 
Half or more of American adults express negative opinions about the way Covid-19 vaccines are distributed, according to a recent survey. . . . → Read More: Infographic – US Public Down on Vaccine Rollout 
A study now underway is tracking long-term effects of Covid-19 infections using real-world data from electronic sources provided by patients. . . . → Read More: Registry Tracking Long-Term Covid-19 Impacts 
The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies 
The U.S. and India are set to produce two-thirds of the world’s Covid-19 vaccine doses by the end of this year, presenting worldwide distribution challenges. . . . → Read More: Infographic – Countries Making Covid-19 Vaccines 
A digital health company is partnering with cancer advocacy organizations to provide electronic therapies to help patients deal with stresses from Covid-19. . . . → Read More: Digital Therapeutics Designed for Cancer/Covid-19 Stress 
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K. . . . → Read More: Vaccine Shown Active Against New Covid-19 Variants 
Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine. . . . → Read More: CureVac, Bayer Partner on Covid-19 Vaccine Supply  One comment - (Comments are closed)  Joint ventures/collaborations  biomedical, biotechnology, clinical trials, Covid-19, Europe, genomics, life sciences, manufacturing, pharmaceuticals |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||